Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Neuropharmacology. 2013 Jan 23;70:112–121. doi: 10.1016/j.neuropharm.2013.01.007

Fig. 3.

Fig. 3

Representative mouse 5-HT2C-VNV-mediated PLC functional data showing the effects of co-administration of 500 nM (−)-PAT (A), 1-methylpsilocin (B), or mCPP (C) with DOI on the ability of DOI to stimulate 5-HT2C receptor-mediated inositol phosphate (IP) production in HEK cells. Note that each of the selective 5-HT2C agonists significantly suppressed the maximal IP response to DOI.